| Literature DB >> 33178368 |
Kathleen Huth1, Patricia Vandecruys1, Julia Orkin1, Hema Patel1.
Abstract
Due to advances in medical care and innovations in health technology, many children with life-limiting conditions are now living longer. These children are often referred to as 'children with medical complexity (CMC)', and they are characterized by chronic conditions, increased health care utilization, and technology dependence. Their complexity of care and inherent fragility lead to higher risk for medication errors, both in-community and in-hospital. High rates of care fragmentation, miscommunication, and polypharmacy in CMC increase opportunities for error, particularly as children transition between health care settings and practitioners. Data on the factors contributing to higher risk of medication errors in this population and how they can be effectively addressed are lacking. This practice point provides clinical guidance for health care professionals to ensure medication safety when caring for CMC, with focus on practical strategies for outpatient and inpatient care. © Canadian Paediatric Society 2020. Published by Oxford University Press on behalf of the Canadian Paediatric Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.Entities:
Keywords: Adverse drug events; Children with medical complexity; Medication; Safety
Year: 2020 PMID: 33178368 PMCID: PMC7606167 DOI: 10.1093/pch/pxaa105
Source DB: PubMed Journal: Paediatr Child Health ISSN: 1205-7088 Impact factor: 2.253